Clinical Course of Abducens Nerve Palsy in Patients with Ruptured Vertebral Artery Dissecting Aneurysms.
abducens nerve palsy
subarachnoid hemorrhage
vertebral artery dissecting aneurysm
Journal
Journal of neuroendovascular therapy
ISSN: 2186-2494
Titre abrégé: J Neuroendovasc Ther
Pays: Japan
ID NLM: 101488164
Informations de publication
Date de publication:
2022
2022
Historique:
received:
31
03
2021
accepted:
16
09
2021
medline:
1
1
2022
pubmed:
1
1
2022
entrez:
28
7
2023
Statut:
ppublish
Résumé
There are few detailed reports on abducens nerve palsy due to a ruptured vertebral artery dissecting aneurysm (VADA). We investigated the clinical characteristics and long-term course of abducens nerve palsy in ruptured VADA patients treated by endovascular surgery. Of the 51 cases of ruptured VADA treated by endovascular intervention from 2011 to 2019, 31 with a good/fair outcome, in which ocular motility disorder was able to be followed, were included and investigated. In all, 11 patients (35.5%) had abducens nerve palsy, and the World Federation of Neurological Surgeons (WFNS) grade and Hunt & Hess (H&H) grade at the time of arrival of patients with abducens nerve palsy were significantly higher than those of patients without abducens nerve palsy. Of the 10 patients who were able to be followed, abducens nerve palsy in 3 completely recovered in 7-180 days. Abducens nerve palsy improved in five patients and remained in two patients. More severe neurological findings on admission reflect a higher rate of abducens nerve palsy. Diplopia induced by abducens nerve palsy is one of the most important sequelae of ruptured VADA, which impairs the daily activities of the patients. Some cases of abducens nerve palsy improve over a long period. Therefore, appropriate diagnosis and follow-up should be concerned.
Identifiants
pubmed: 37502345
doi: 10.5797/jnet.oa.2021-0060
pii: jnet.oa.2021-0060
pmc: PMC10370914
doi:
Types de publication
Journal Article
Langues
eng
Pagination
339-345Informations de copyright
©2022 The Japanese Society for Neuroendovascular Therapy.
Déclaration de conflit d'intérêts
All authors submitted the self-certification form of conflicts of interest to the Japanese Society for Neuroendovascular Therapy. They have no conflicts of interest to declare concerning this paper.
Références
Interv Neuroradiol. 2018 Jun;24(3):254-262
pubmed: 29433365
Cerebrovasc Dis. 2007;24(6):516-9
pubmed: 17971630
Surg Radiol Anat. 2012 Jan;34(1):3-14
pubmed: 21750991
Acta Neurochir (Wien). 1974;30(1-2):119-28
pubmed: 4414886
Ophthalmology. 2004 Feb;111(2):369-75
pubmed: 15019392
Curr Neurol Neurosci Rep. 2016 Aug;16(8):69
pubmed: 27306521
Asian J Neurosurg. 2018 Jul-Sep;13(3):572-576
pubmed: 30283507
J Cereb Blood Flow Metab. 2006 Nov;26(11):1341-53
pubmed: 16482081
Neurosurg Rev. 1988;11(2):137-41
pubmed: 3244411
World Neurosurg. 2018 Aug;116:e505-e512
pubmed: 29758373
Springerplus. 2015 Dec 10;4:765
pubmed: 26688779
J Neurol Sci. 2014 Nov 15;346(1-2):284-7
pubmed: 25245175